A Agilent Technologies, Inc. Common Stock

NYSE · US · Healthcare · Diagnostics & Research · agilent.com

170.12USD+1.39%Mkt Cap: 47.30B $P/E: 33.09Today

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Mark…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$14.05BUSDP/E 26.2

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

GRAL

GRAIL, Inc. - Common Stock

$6.40BUSD

Key Statistics

Company

Market Cap47.30B USD

Enterprise Value49.69B USD

Revenue (TTM)7.37B USD

Gross Profit3.64B USD

Net Income (TTM)1.30B USD

Revenue/Share26.10 USD

Last Price170.12 USD

Fiscal Year EndOct 2025

MR QuarterJul 2026

Employees18.2K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)33.09

P/E (Forward)24.83

PEG1.39

EV/EBITDA23.89

EV/Revenue6.74

P/S6.42

P/B6.43

EPS (TTM)5.07

EPS (Forward)6.76

52W Range

108.3590% of range177.05

52W High177.05 USD

52W Low108.35 USD

Profitability

Gross Margin52.43%

Oper. Margin25.56%

EBITDA Margin28.21%

Profit Margin18.75%

ROE19.33%

ROA10.24%

Growth

Revenue Growth8.10%

Earnings Growth8.50%

Cash Flow & Leverage

Operating CF1.56B USD

CapEx (TTM)407.00M USD

FCF Margin14.38%

FCF Yield2.24%

Net Debt2.39B USD

Net Debt/EBITDA1.15

Balance Sheet

Debt/Equity0.50

Current Ratio2.05

Quick Ratio1.41

Book Value/Sh26.11 USD

Cash/Share6.24 USD

Dividends

Fwd Div Rate1.02 USD

Trail. Div Rate1.01 USD

Div. Yield0.61%

5Y Avg Yield0.68%

Payout Ratio19.98%

Ex-Div DateOct 6, 2026

Pay DateOct 28, 2026

Splits

Last Split1398:1000

Split DateNov 3, 2014

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)175.20 USD

Upside (mean)+3.0%

Target Range155.00 USD – 190.00 USD

155.00+3.0% to mean190.00

# Analysts20

Ownership

Shares Out.281.93M

Float280.96M

Insiders0.19%

Institutions95.40%

Short Interest

Short Ratio2.1d

Short % Float2.05%

Short % Out.1.80%

Shares Short5.08M

Short (prev mo.)5.17M

Technical

SMA 50152.53 (+11.5%)

SMA 200132.83 (+28.1%)

Beta1.24

S&P 52W Chg14.58%

Avg Vol (30d)2.46M

Avg Vol (10d)2.73M

Technical Indicators

RSI (14)61.3

MACD6.2044

MACD Signal5.7107

MACD Hist.+0.4937

BB Upper182.16 USD

BB Middle159.66 USD

BB Lower137.16 USD

BB Width28.18%

ATR (14)4.889 USD

Vol Ratio (20d)0.88x